/persons/resource/persons147301
Sos,
Martin L.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
Rode,
Haridas B.
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany;
2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany;
3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan;
4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School,
5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;
6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;
/persons/resource/persons147194
Heynck,
Stefanie
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
/persons/resource/persons147255
Peifer,
Martin
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
/persons/resource/persons147167
Fischer,
Florian
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
Klüter,
Sabine
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany;
2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany;
3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan;
4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School,
5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;
6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;
Pawar,
Vijakumar G.
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany;
2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany;
3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan;
4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School,
5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;
6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;
/persons/resource/persons147268
Reuter,
Cecile
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
/persons/resource/persons147193
Heuckmann,
Johannes M.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
/persons/resource/persons147338
Weiss,
Jonathan
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
Ruddigkeit,
Lars
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany;
2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany;
3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan;
4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School,
5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;
6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;
Rabiller,
Matthias
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany;
2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany;
3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan;
4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School,
5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;
6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;
/persons/resource/persons147213
Koker,
Mirjam
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
Simard,
Jeffrey R.
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany;
2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany;
3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan;
4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School,
5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;
6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;
Getlik,
Matthäus
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany;
2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany;
3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan;
4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School,
5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;
6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;
Yuza,
Yuki
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany;
2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany;
3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan;
4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School,
5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;
6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;
Chen,
Tzu-Hsiu
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany;
2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany;
3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan;
4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School,
5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;
6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;
Greulich,
Heidi
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany;
2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany;
3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan;
4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School,
5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;
6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;
/persons/resource/persons147315
Thomas,
Roman K.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;
Rauh,
Daniel
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany;
2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany;
3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan;
4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School,
5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;
6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;